承業醫 (4164): 富康 shareholders' meeting approves 李沛霖's reappointment as chairman - Global Bio & Investment Monthly
Summary not yet available
Companies mentioned：承業醫、富康
2026-09-17 18:00–21:00 JST
203 received, 203 listed, 4 sources ・ Page 3 of 3
One place for news and notices from 1 countries/regions: Taiwan, 203 items from 4 sources.
One edition every 180 minutes: every item from every source received in the period, with the original link.
Taiwan | 環球生技月刊 (continued)（9）
高端疫苗二 (65472) bonds to be redeemed starting 10/8; OTC trading to end on 11/9 - Global Bio & Investment Monthly
Summary not yet available
Facts
- Code: 65472
Companies mentioned：高端疫苗、高端疫苗二
09/17 Bio Stock Updates - Global Bio & Investment Monthly
Summary not yet available
Facts
- Capital reduction of NT$170 million
- Paid-in capital of NT$100 million
- 昱展新藥 9.94%
- 禾榮科 9.85%
- 漢達 9.7%
- 浩宇生醫 9.09%
- 杏國 6.68%
- 睿生光電 6.28%
Companies mentioned：通用幹細胞、昱展新藥、禾榮科、漢達、浩宇生醫、杏國、睿生光電